Jacobs Levy Equity Management
FBIO icon

Jacobs Levy Equity Management’s Fortress Biotech FBIO Stock Holding History

Jacobs Levy Equity Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-29,260
Closed -$597K – 1024
2022
Q1 		$597K Sell
29,260
-22
-0.1% -$602 ﹤0.01% 837
2021
Q4 		$1.1M Buy
+29,282
New +$1.31M 0.01% 726
2021
Q3 		– Sell
-1,641
Closed -$88K – 1064
2021
Q2 		$88K Sell
1,641
-197
-11% -$11.9K ﹤0.01% 1012
2021
Q1 		$97K Buy
1,838
+1,102
+150% +$62.2K ﹤0.01% 995
2020
Q4 		$35K Sell
736
-8,458
-92% -$366K ﹤0.01% 1005
2020
Q3 		$557K Sell
9,194
-178
-2% -$9.07K 0.01% 768
2020
Q2 		$377K Buy
9,372
+2,899
+45% +$108K ﹤0.01% 842
2020
Q1 		$184K Hold
6,473
– – ﹤0.01% 898
2019
Q4 		$250K Hold
6,473
– – ﹤0.01% 901
2019
Q3 		$137K Sell
6,473
-1,920
-23% -$45.1K ﹤0.01% 874
2019
Q2 		$189K Hold
8,393
– – ﹤0.01% 880
2019
Q1 		$224K Sell
8,393
-11,673
-58% -$306K ﹤0.01% 879
2018
Q4 		$259K Buy
20,066
+5,987
+43% +$100K ﹤0.01% 833
2018
Q3 		$338K Buy
14,079
+5,230
+59% +$167K ﹤0.01% 853
2018
Q2 		$396K Buy
8,849
+5,504
+165% +$310K 0.01% 845
2018
Q1 		$228K Sell
3,345
-2,666
-44% -$169K ﹤0.01% 903
2017
Q4 		$360K Buy
6,011
+3,684
+158% +$217K 0.01% 811
2017
Q3 		$154K Buy
+2,327
New +$157K ﹤0.01% 895
2015
Q3 		– Sell
-1,985
Closed -$100K – 826
2015
Q2 		$100K Sell
1,985
-3,445
-63% -$177K ﹤0.01% 762
2015
Q1 		$314K Buy
+5,430
New +$226K 0.01% 645

Other funds holding FBIO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Jacobs Levy Equity Management's FBIO Position: Q2 2022 in Review

Jacobs Levy Equity Management sold out of Fortress Biotech (FBIO) in Q2 2022, closing a stake of 29,260 shares — an estimated $597K sold.

Jacobs Levy Equity Management first reported a position in FBIO in Q1 2015 and held it in 20 quarters. The position peaked at $1.1M in Q4 2021. 66 funds tracked by Wall St. Rank hold FBIO as of Q2 2022.

  • Jacobs Levy Equity Management reported no remaining Fortress Biotech position as of Q2 2022 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 29,260 Fortress Biotech shares in Q2 2022, an estimated $597K.
  • Jacobs Levy Equity Management first reported a position in Fortress Biotech in Q1 2015 and held it in 20 quarters.
  • Jacobs Levy Equity Management's Fortress Biotech position peaked at $1.1M in Q4 2021.
  • 66 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2022.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2022, filed 15 Aug 2022.